Sio Capital Management »

Rapport Therapeutics shares owned by Sio Capital Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.5M 185k 29.70

More positions owned by Sio Capital Management

Maximus (MMS)
Celcuity (CELC)
Sanofi Sa Sponsored Adr (SNY)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Disc Medicine (IRON)
Merck & Co (MRK)
Henry Schein (HSIC)
Centene Corporation (CNC)
Kenvue (KVUE)
BioMarin Pharmaceutical (BMRN)
GSK Sponsored Adr (GSK)
Bright Minds Biosciences Com New (DRUG)
Haemonetics Corporation (HAE)
Aquestive Therapeutics (AQST)

View all positions for Sio Capital Management

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics